Literature DB >> 12240795

The Diabcare-Asia 1998 study--outcomes on control and complications in type 1 and type 2 diabetic patients.

W Nitiyanant1, S Tandhanand, H Mahtab, X X Zhu, C Y Pan, B S Raheja, S R Sathe, S Soegondo, P Soewondo, Y S Kim, M Embong, L Lantion-Ang, M A Lim-Abraham, W W R Lee, M Wijesuriya, T Y Tai, L M Chuang, H L Le, C Cockram, L N Jorgensen, J P Yeo.   

Abstract

UNLABELLED: The aim of this study was to describe the glycaemic and metabolic control and diabetes-related complications in type 1 and type 2 Asian patients.
METHODS: Data of diabetes patients from 230 diabetes centres in 12 Asian regions were collected on a retrospective-prospective basis through review of medical records, interview and laboratory assessments. Analysis of glycated haemoglobin (HbA1c) was carried out in central laboratories appointed by Bio-Rad. The data collection case record forms were scanned electronically.
RESULTS: 22177 patients with valid data made up the analysis population. Among patents with type 1 and type 2 diabetes, there was a higher proportion of women than men (53% vs. 47% for type 1 patients and 56% vs. 44% for type 2 diabetes). Hypertension (61%) and overweight (40% with BMI > or = 25 kg/m2 were common in type 2 patients. Dyslipidaemia was also present in at least half of both types of patients. Control of glycaemia (mean HbA,1c and fasting blood glucose [FBG]) was poor in type 1 (9.9 +/- 2.5%; 10.2 +/- 5.2 mmol/l) and type 2 patients (8.5 +/- 2.0%; 8.9 +/- 3.4 mmol/l). Glycaemia in the majority of both types of patients fell short of those stipulated by various guidelines. In type 2 patients, glycaemia deteriorated (HbA1c > 7.5%, FBG > or = 7.0 mmol/l) with duration of diabetes > 7 years. Both types of diabetes appear to share a similar high prevalence of complications of cataract, retinopathy and neuropathy, although the prevalence of cataract (27%) and neuropathy (35%) was higher in type 2 diabetes. Screening for microalbuminuria was not common.
CONCLUSIONS: The Inadequate metabolic and hypertension control, especially in type 2 patients, needs to be addressed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12240795     DOI: 10.1185/030079902125000822

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  6 in total

Review 1.  Patient-reported assessments in diabetes care: clinical and research applications.

Authors:  Soren E Skovlund
Journal:  Curr Diab Rep       Date:  2005-04       Impact factor: 4.810

2.  Diabcare Asia 2001--Korea country report on outcome data and analysis.

Authors:  Sang Youl Rhee; Young Seol Kim; Seungjoon Oh; Woong Hwan Choi; Jong Eun Park; Woo Jin Jeong
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

3.  Factors Associated with Glycaemic Control among Diabetic Patients Managed at an Urban Hospital in Hanoi, Vietnam.

Authors:  Luu Quang Thuy; Hoang Thi Phuong Nam; Tran Thi Ha An; Bui Van San; Tran Nguyen Ngoc; Le Hong Trung; Pham Huy Tan; Nguyen Hoang Thanh
Journal:  Biomed Res Int       Date:  2021-02-24       Impact factor: 3.411

4.  Current status of management, control, complications and psychosocial aspects of patients with diabetes in India: Results from the DiabCare India 2011 Study.

Authors:  Viswanathan Mohan; Siddharth N Shah; Shashank R Joshi; V Seshiah; Binode Kumar Sahay; Samar Banerjee; Subhash Kumar Wangnoo; Ajay Kumar; Sanjay Kalra; A G Unnikrishnan; Surendra Kumar Sharma; P V Rao; Shahid Akhtar; Raman V Shetty; Ashok Kumar Das
Journal:  Indian J Endocrinol Metab       Date:  2014-05

5.  DiabCare survey of diabetes management and complications in the Gulf countries.

Authors:  Muhamed Shahed Omar; Khaled Khudada; Saher Safarini; Sherif Mehanna; Jalal Nafach
Journal:  Indian J Endocrinol Metab       Date:  2016 Mar-Apr

Review 6.  Diagnosing peripheral neuropathy in South-East Asia: A focus on diabetic neuropathy.

Authors:  Rayaz A Malik; Aimee Andag-Silva; Charungthai Dejthevaporn; Manfaluthy Hakim; Jasmine S Koh; Rizaldy Pinzon; Norlela Sukor; Ka Sing Wong
Journal:  J Diabetes Investig       Date:  2020-05-21       Impact factor: 4.232

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.